Novartis adquire desenvolvedora de tratamento contra câncer de medula óssea por US$ 2,9 bilhões
07 February 2024 - 7:15AM
Newspaper
/jornal/2024/02/novartis-adquire-desenvolvedora-de-tratamento-contra-cancer-de-medula-ossea-por-us-2-9-bilhoes/
Novartis (BOV:N1VS34)
Historical Stock Chart
From May 2024 to Jun 2024
Novartis (BOV:N1VS34)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Novartis AG (Brazil Bovespa Exchange): 0 recent articles
More News Articles